Microbiology and management of endodontic infections in children.
The first step in the origination of caries is the formation of a dental plaque. Dental caries can lead to destruction of enamel and dentin resulting in bacterial invasion of the pulp. Invasion of the pulp and the periapical areas can promote the development of dento-alveolar abscess and spread of the infection to other anatomical areas. Several oral acid producing aerobic and anaerobic bacteria, including Streptococcus mutans, Lactobacillus acidophilus, and Actinomyces viscosus, are capable of initiating the carious lesion. The organisms that predominate in pulpitis and dento-alveolar abscess are Prevotella, Porphyromonas, Fusobacterium, and Peptostreptococcus spp. Treatment of caries involves removal of all affected tooth structure and proper replacement with a restorative material. Once pulpitis has developed the infected tissue should be removed and root canal therapy instituted, or the tooth should be extracted. Extraction, root canal therapy and/or drainage of pus usually are indicated for an abscess. Antimicrobial therapy supplementing the dental care should be considered, especially when local or systemic spread of the infection is suspected. Penicillin or amoxicillin are generally effective against most of the aerobic and anaerobic bacteria recovered. The patient whose oral cavity may harbor penicillin-resistant organisms should be considered for treatment with drugs effective against these organisms. These agents include amoxicillin-clavulanate, clindamycin or the combination of metronidazole plus amoxicillin or a macrolide.
Brook
Itzhak
I
Georgetown University School of Medicine, Washington DC, USA. ib6@georgetown.edu
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001421:Bacteria, Anaerobic / Q000472:pathogenicity; D001424:Bacterial Infections / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D003731:Dental Caries / Q000382:microbiology / Q000628:therapy; D004322:Drainage; D006801:Humans; D007778:Lactobacillus / Q000472:pathogenicity; D010482:Periapical Abscess / Q000382:microbiology* / Q000628:therapy; D011671:Pulpitis / Q000382:microbiology* / Q000628:therapy; D012390:Root Canal Therapy; D013295:Streptococcus mutans / Q000472:pathogenicity
D000900:Anti-Bacterial Agents